European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.

By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA ...

The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.

Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...

この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2024年9月30日（現地時間）に発表したものを日本語に翻訳したもので、報道関係者の皆さまに参考資料として提供するものです。資料の内容および解釈については、英語が優先されます。英語版は ...

メッセンジャーRNA（mRNA）ワクチンを用いた新たな治療法により、加齢黄斑変性をマウスモデルで抑制することに成功しました。 網膜で異常に産生される分子LRG1に対し、mRNAワクチンにより抗体を誘導し、その機能を抑制することで病態の進行を抑えました ...

Oklahoma has always valued independence, common sense and practical solutions. mRNA therapeutics help doctors do no harm and ...